Literature DB >> 23053715

1H NMR analysis of choline metabolites in fine-needle-aspirate biopsies of breast cancer.

John M Pearce1, Mary C Mahoney, Jing-Huei Lee, Wen-Jang Chu, Kim M Cecil, Stephen M Strakowski, Richard A Komoroski.   

Abstract

OBJECT: The relative amounts of choline (Cho), phosphocholine (PC), and glycerophosphocholine (GPC) may be sensitive indicators of breast cancer and the degree of malignancy. Here we implement some simple modifications to a previously developed (1)H NMR analysis of fine-needle-aspirate (FNA) biopsies designed to yield sufficient spectral resolution of Cho, PC, and GPC for usable relative quantitation of these metabolites.
MATERIALS AND METHODS: FNA biopsies of eighteen breast lesions were examined using our modified procedure for direct (1)H NMR at 400 MHz. Resonances of choline metabolites and potential interferences were fit using the computer program NUTS.
RESULTS: Quantitation of PC, GPC, and Cho relative to each other and to (phospho)creatine was obtained for eleven confirmed cases of infiltrating ductal carcinoma. Reliable results could not be obtained for the remaining cases primarily due to interference from lidocaine anesthetic.
CONCLUSION: Some simple modifications of a previously developed (1)H NMR analysis of FNAs yielded sufficient spectral resolution of Cho, PC, and GPC to permit usable relative quantitation at 400 MHz. In 9 of the 11 quantified cases the sum of GPC and Cho exceeded 42 % of the total choline-metabolite peak area.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053715     DOI: 10.1007/s10334-012-0349-0

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  27 in total

1.  High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues.

Authors:  Olaf Beckonert; Muireann Coen; Hector C Keun; Yulan Wang; Timothy M D Ebbels; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-05-13       Impact factor: 13.491

2.  Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.

Authors:  Beathe Sitter; Tone F Bathen; Trond E Singstad; Hans E Fjøsne; Steinar Lundgren; Jostein Halgunset; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2010-01-25       Impact factor: 4.044

Review 3.  Choline metabolism in malignant transformation.

Authors:  Kristine Glunde; Zaver M Bhujwalla; Sabrina M Ronen
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

4.  Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.

Authors:  W B Mackinnon; P A Barry; P L Malycha; D J Gillett; P Russell; C L Lean; S T Doran; B H Barraclough; M Bilous; C E Mountford
Journal:  Radiology       Date:  1997-09       Impact factor: 11.105

5.  Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.

Authors:  Rachel Katz-Brull; Dalia Seger; Dalia Rivenson-Segal; Edna Rushkin; Hadassa Degani
Journal:  Cancer Res       Date:  2002-04-01       Impact factor: 12.701

Review 6.  MR evaluation of response to targeted treatment in cancer cells.

Authors:  Franca Podo; Silvana Canevari; Rossella Canese; Maria Elena Pisanu; Alessandro Ricci; Egidio Iorio
Journal:  NMR Biomed       Date:  2011-03-08       Impact factor: 4.044

7.  31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.

Authors:  Dennis W J Klomp; Bart L van de Bank; Alexander Raaijmakers; Mies A Korteweg; Cecilia Possanzini; Vincent O Boer; Cornelius A T van de Berg; Maurice A A J van de Bosch; Peter R Luijten
Journal:  NMR Biomed       Date:  2011-03-24       Impact factor: 4.044

8.  High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies.

Authors:  Jack J A van Asten; Vincent Cuijpers; Christina Hulsbergen-van de Kaa; Claudia Soede-Huijbregts; J Alfred Witjes; Albert Verhofstad; Arend Heerschap
Journal:  MAGMA       Date:  2008-11-25       Impact factor: 2.310

9.  31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.

Authors:  Richard A Komoroski; John M Pearce; Robert E Mrak
Journal:  Magn Reson Med       Date:  2008-03       Impact factor: 4.668

10.  A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.

Authors:  T A Smith; J Glaholm; M O Leach; L Machin; D J Collins; G S Payne; V R McCready
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  6 in total

1.  Choline kinase β mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone mass.

Authors:  Jasreen Kular; Jennifer C Tickner; Nathan J Pavlos; Helena M Viola; Tamara Abel; Bay Sie Lim; Xiaohong Yang; Honghui Chen; Robert Cook; Livia C Hool; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

2.  Alteration in lipid composition differentiates breast cancer tissues: a 1H HRMAS NMR metabolomic study.

Authors:  Anup Paul; Surendra Kumar; Anubhav Raj; Abhinav A Sonkar; Sudha Jain; Atin Singhai; Raja Roy
Journal:  Metabolomics       Date:  2018-09-03       Impact factor: 4.290

3.  1H MR Spectroscopy of Fine-Needle Aspiration Biopsy Specimens for the Discrimination of Breast Cancer.

Authors:  Richard A Komoroski; Jing-Huei Lee; Jeffrey A Welge; Jonathan A Dudley; Wen-Jang Chu; Mary C Mahoney
Journal:  Radiol Imaging Cancer       Date:  2020-11-27

4.  Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy.

Authors:  Jack J A van Asten; Riyas Vettukattil; Tessa Buckle; Sven Rottenberg; Fijs van Leeuwen; Tone F Bathen; Arend Heerschap
Journal:  J Transl Med       Date:  2015-04-09       Impact factor: 5.531

5.  Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy.

Authors:  Rita Araújo; Victoria Fabris; Caroline A Lamb; Claudia Lanari; Luisa A Helguero; Ana M Gil
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

6.  A Crosstalk- and Interferent-Free Dual Electrode Amperometric Biosensor for the Simultaneous Determination of Choline and Phosphocholine.

Authors:  Rosanna Ciriello; Antonio Guerrieri
Journal:  Sensors (Basel)       Date:  2021-05-19       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.